Principal Financial Group Inc. boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 238,305 shares of the medical device company's stock after purchasing an additional 14,687 shares during the quarter. Principal Financial Group Inc. owned about 0.12% of Cooper Companies worth $26,295,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of COO. Raymond James Trust N.A. increased its position in Cooper Companies by 23.0% during the 2nd quarter. Raymond James Trust N.A. now owns 2,567 shares of the medical device company's stock valued at $224,000 after purchasing an additional 480 shares during the period. Kintegral Advisory LLC purchased a new stake in Cooper Companies during the second quarter worth $1,093,000. Strategic Blueprint LLC boosted its position in Cooper Companies by 4.3% during the 2nd quarter. Strategic Blueprint LLC now owns 5,130 shares of the medical device company's stock valued at $448,000 after acquiring an additional 213 shares in the last quarter. HB Wealth Management LLC bought a new stake in Cooper Companies during the 2nd quarter valued at $220,000. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Cooper Companies by 92.7% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,218 shares of the medical device company's stock valued at $106,000 after acquiring an additional 586 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms recently commented on COO. Morgan Stanley reduced their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Friday, December 6th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, December 6th. Citigroup reduced their price target on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research report on Friday, December 6th. Piper Sandler upped their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a report on Thursday, August 29th. Finally, StockNews.com cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $117.00.
View Our Latest Report on Cooper Companies
Cooper Companies Price Performance
NASDAQ COO traded up $0.29 on Wednesday, hitting $92.81. The company had a trading volume of 451,163 shares, compared to its average volume of 1,176,626. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market capitalization of $18.52 billion, a PE ratio of 47.60, a PEG ratio of 2.52 and a beta of 0.97. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38. The company's fifty day moving average price is $101.26 and its 200-day moving average price is $98.88.
Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company's revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.87 EPS. As a group, analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.
About Cooper Companies
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
See Also
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.